|
ZNF548 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.62636570877339E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
7.153200E-01 |
| Stage1-vs-Stage3 |
7.440000E-02 |
| Stage1-vs-Stage4 |
2.380900E-03 |
| Stage2-vs-Stage3 |
2.881800E-01 |
| Stage2-vs-Stage4 |
3.543800E-02 |
| Stage3-vs-Stage4 |
1.864640E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.18371978885534E-12 |
| Normal-vs-Asian |
4.44089209850063E-16 |
| Caucasian-vs-AfricanAmerican |
9.649400E-01 |
| Caucasian-vs-Asian |
8.603600E-01 |
| AfricanAmerican-vs-Asian |
8.692000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.900800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.354060E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.447800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.586990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.127800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.753780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.958800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.327000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.558700E-04 |
| Classical-VS-Follicular |
7.665200E-01 |
| Classical-VS-Other |
7.196400E-01 |
| Classical-VS-Normal |
2.1094237467878E-15 |
| Tall-VS-Follicular |
6.358300E-02 |
| Tall-VS-Other |
4.375800E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
6.832800E-01 |
| Follicular-VS-Normal |
3.14430037562374E-10 |
| Other-VS-Normal |
9.96599999999459E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
2.536000E-01 |
|
|
